Cargando…
CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII
Regulatory T cells (Tregs) control immune responses in autoimmune disease, transplantation, and enable antigen-specific tolerance induction in protein-replacement therapies. Tregs can exert a broad array of suppressive functions through their T cell receptor (TCR) in a tissue-directed and antigen-sp...
Autores principales: | Rana, Jyoti, Perry, Daniel J., Kumar, Sandeep R.P., Muñoz-Melero, Maite, Saboungi, Rania, Brusko, Todd M., Biswas, Moanaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417451/ https://www.ncbi.nlm.nih.gov/pubmed/33940160 http://dx.doi.org/10.1016/j.ymthe.2021.04.034 |
Ejemplares similares
-
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response
por: Baeuerle, Patrick A., et al.
Publicado: (2019) -
B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin
por: Biswas, Moanaro, et al.
Publicado: (2020) -
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models
por: Lesch, Stefanie, et al.
Publicado: (2022) -
Reprogrammed CD4(+) T Cells That Express FoxP3(+) Control Inhibitory Antibody Formation in Hemophilia A Mice
por: Herzog, Roland W., et al.
Publicado: (2019) -
Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors
por: Ding, Jian, et al.
Publicado: (2023)